Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.

Aurran-Schleinitz T, Letestu R, Sartor M, Mulligan S, Béné MC, Cull G, Carney D, Renwick W, Grigg A, Forsyth C, Hapgood G, Verner E, Harrup R, Warburton P, Mason K, Eek R, Janowski W, Vilque JP, Latimer M, Voillat L, De Guibert S, Drenou B, Blum R, Dartigeas C, Hayes L, Daguindau N, Tiab M, Leblond V, Shearer A, Lasica M, Morel P, Slama B, Banos A, Brion A, Ferrant E, Michel J, Tomowiak C, Morris E, Sia H, Kratzing K, Butcher BE, Dahmani A, Larsen SR, Blombery P, Cymbalista F, Gottlieb DJ

Open source

DOI
10.1111/bjh.70850
Published
2026 Sep 20
Container
British journal of haematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70850,
  title = {Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.},
  author = {Aurran-Schleinitz T and Letestu R and Sartor M and Mulligan S and Béné MC and Cull G and Carney D and Renwick W and Grigg A and Forsyth C and Hapgood G and Verner E and Harrup R and Warburton P and Mason K and Eek R and Janowski W and Vilque JP and Latimer M and Voillat L and De Guibert S and Drenou B and Blum R and Dartigeas C and Hayes L and Daguindau N and Tiab M and Leblond V and Shearer A and Lasica M and Morel P and Slama B and Banos A and Brion A and Ferrant E and Michel J and Tomowiak C and Morris E and Sia H and Kratzing K and Butcher BE and Dahmani A and Larsen SR and Blombery P and Cymbalista F and Gottlieb DJ},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70850},
  url = {https://doi.org/10.1111/bjh.70850}
}

RIS

TY  - JOUR
TI  - Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.
AU  - Aurran-Schleinitz T
AU  - Letestu R
AU  - Sartor M
AU  - Mulligan S
AU  - Béné MC
AU  - Cull G
AU  - Carney D
AU  - Renwick W
AU  - Grigg A
AU  - Forsyth C
AU  - Hapgood G
AU  - Verner E
AU  - Harrup R
AU  - Warburton P
AU  - Mason K
AU  - Eek R
AU  - Janowski W
AU  - Vilque JP
AU  - Latimer M
AU  - Voillat L
AU  - De Guibert S
AU  - Drenou B
AU  - Blum R
AU  - Dartigeas C
AU  - Hayes L
AU  - Daguindau N
AU  - Tiab M
AU  - Leblond V
AU  - Shearer A
AU  - Lasica M
AU  - Morel P
AU  - Slama B
AU  - Banos A
AU  - Brion A
AU  - Ferrant E
AU  - Michel J
AU  - Tomowiak C
AU  - Morris E
AU  - Sia H
AU  - Kratzing K
AU  - Butcher BE
AU  - Dahmani A
AU  - Larsen SR
AU  - Blombery P
AU  - Cymbalista F
AU  - Gottlieb DJ
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70850
UR  - https://doi.org/10.1111/bjh.70850
ER  -

APA

T, A., R, L., M, S., S, M., MC, B., G, C., D, C., W, R., A, G., C, F., G, H., E, V., R, H., P, W., K, M., R, E., W, J., JP, V., M, L., L, V., S, D. G., B, D., R, B., C, D., L, H., N, D., M, T., V, L., A, S., M, L., P, M., B, S., A, B., A, B., E, F., J, M., C, T., E, M., H, S., K, K., BE, B., A, D., SR, L., P, B., F, C., & DJ, G. (2026). Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.. British journal of haematology. https://doi.org/10.1111/bjh.70850

Source records